Test-retest reliability of health state valuations collected with the EuroQol questionnaire

Agt, Heleen van; Essink‐Bot, Marie‐Louise; Krabbe, Paul F M; Bonsel, Gouke J.

doi:10.1007/1-4020-3712-0_9

Cited by 42 publications

(54 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The EuroQOL-5D-3L is a well-validated, 18,19 preference-based, QOL instrument that measures healthrelated QOL in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) using 3 levels (no problems, some problems, and severe problems). A vertically oriented visual analog scale generates a selfreported current "health state."…”

Section: Methodsmentioning

confidence: 99%

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer

Lango

Egleston

Fang

et al. 2013

Cancer

View full text Add to dashboard Cite

Introduction Baseline dysphagia, more common than abnormalities on formal swallowing testing, is believed to predict survival in untreated head and neck cancer patients. We hypothesized that patient-reported dysphagia impacts multiple domains of quality of life and predicts disease recurrence and disease-related death. Methods The Swal-QOL, a dysphagia-specific measure, and the EuroQOL were administered to 159 patients prior to treatment with curative intent, in this prospective cross-sectional cohort study. Logistic regression evaluated associations among clinical and subjective measures. Multivariable competing risk regression tested the impact of clinical, tumor and patient-reported measures on survival. Results Baseline dysphagia, pain and diminished patient-reported health state (PRHS) were more closely associated with weight loss prior to treatment and advanced T-classification, than any other clinical feature. However, only 56% (23/40) of patients reporting dysphagia had >5% weight loss. Dysphagia was associated with pain and/or diminished PRHS, independent of weight loss. Female patients were more likely to report pain and dysphagia, while males reported dysphagia alone. Dysphagia predicted recurrence and disease related death, adjusting for T and N classification, performance status, smoking and weight loss, and accounting for competing risks of death (RFS: HR 3.8 (95%CI 1.7–8.4), p=.001; DOD HR 4.2 (95%CI 1.04–5), p=.004). Conclusion Baseline dysphagia affects multiple domains of quality of life and general health perceptions in untreated head and neck cancer patients. A dysphagia measure captures the effort of maintaining nutrition with cancer, identifying patients with or at risk for weight loss, and predisposed to disease recurrence and disease-related death.

show abstract

Section: Methodsmentioning

confidence: 99%

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer

Lango

Egleston

Fang

et al. 2013

Cancer

View full text Add to dashboard Cite

show abstract

“…Health variables included medication use; obesity (BMI≥ 30 kg/m²); the European Quality of Life Scale 5‐D (12) that covers five dimensions associated with health (mobility, leisure, self‐care, main role, family and leisure activities, and pain and mood – although scores can be summed to create a mean score, we analysed these separately) has good reliability (13) and reasonable validity (14); the General Health Questionnaire (GHQ‐12) (15), a self‐administered screening instrument with good reliability and validity (16,17), widely used to detect current psychiatric disorders (a cut‐off of 2/3 is used to detect psychiatric conditions such as depression or anxiety); and perceived social support that was based on seven questions regarding perceptions of contact with people who offer happiness, love, care, acceptance, importance, support and encouragement. A low score demonstrated greater levels of perceived social support.…”

Section: Methodsmentioning

confidence: 99%

Complementary and alternative medicine use in England: results from a national survey

Hunt¹,

Coelho²,

Wider³

et al. 2010

International Journal of Clinical Practice

228

174

View full text Add to dashboard Cite

Summary Objectives: In many countries, recent data on the use of complementary and alternative medicine (CAM) are available. However, in England, there is a paucity of such data. We sought to determine the prevalence and predictors of CAM use in England. Design: Data were obtained from the Health Survey for England 2005, a national household survey that included questions on CAM use. We used binary logistic regression modelling to explore whether demographic, health and lifestyle factors predict CAM use. Results: Data were available for 7630 respondents (household response rate 71%). Lifetime and 12‐month prevalence of CAM use were 44.0% and 26.3% respectively; 12.1% had consulted a practitioner in the preceding 12 months. Massage, aromatherapy and acupuncture were the most commonly used therapies. Twenty‐nine percent of respondents taking prescription drugs had used CAM in the last 12 months. Women (OR 0.491, 95% CI: 0.419, 0.577), university educated respondents (OR 1.296, 95% CI: 1.088, 1.544), those suffering from anxiety or depression (OR 1.341, 95% CI: 1.074, 1.674), people with poorer mental health (on GHQ: OR 1.062, 95% CI 1.026, 1.100) and lower levels of perceived social support (1.047, 95% CI: 1.008, 1.088), people consuming ≥ 5 portions of fruit and vegetables a day (OR 1.327, 95% CI: 1.124, 1.567) were significantly more likely to use CAM. Conclusion: Complementary and alternative medicine use in England remains substantial, even amongst those taking prescription drugs. These data serve as a valuable reminder to medical practitioners to ask patients about CAM use and should be routinely collected to facilitate prioritisation of the research agenda in CAM.

show abstract

“…Health‐related quality of life was assessed with a generic measure of health status, the EuroQol‐5 Dimensions (EQ‐5D) questionnaire [20–22]. EQ‐5D consists of five domains (mobility, self‐care, usual activities, pain/discomfort and anxiety/depression) [23].…”

Section: Methodsmentioning

confidence: 99%

Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France

Vexiau

Mavros

Krishnarajah

et al. 2008

Diabetes Obesity Metabolism

View full text Add to dashboard Cite

show abstract

Test-retest reliability of health state valuations collected with the EuroQol questionnaire

Cited by 42 publications

References 12 publications

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer

Complementary and alternative medicine use in England: results from a national survey

Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France

Contact Info

Product

Resources

About